New Users Registration  |  Useful Links  |  FAQ  |  Site Map 
Go Search


Skip Navigation LinksHealth Xchange > News
  News Article  

 S’pore, US firms in pandemic flu vaccine tie-up

  Saturday, 28 l 08 l 2010 Source: The Straits Times   
By: Grace Chua

TEMASEK Life Sciences Ventures (TLV) this month announced a joint venture to develop a pandemic flu vaccine with a United States biotech firm.

TLV, the commercialisation arm of Temasek Life Sciences Laboratories, will work with Maryland-deadquartered Emergent BioSolutions to develop, manufacture and commercialise the flu vaccine.

The vaccine will target a number of H5 influenza strains, which circulate in bird populations like poultry and can be transmitted to humans.

In particular, the H5N1 flu virus has been singled out as a potential pandemic if it mutates to spread easily from person to person. Sixty per cent of people infected by the virus do not survive.

The Singapore-based joint venture, called EPIC BIO, aims to begin manufacturing next year and start clinical trials in 2012.

On the basic research front, Temasek Life Sciences Laboratories last week signed a memorandum of
understanding with Japan’s National Institute for Basic Biology for a five-year tie-up to study plants and animals.

The institutes will conduct joint research, host visiting researchers and graduate exchange students, and focus on projects involving model organisms such as fruit flies and zebrafish.

  Ask the Specialists - Free Doctor Q&A  
    Previous Q&As
Check out our archive for all our previous doctor's Q&As!
*Latest Update:
- Pain associated with diabetes
- Child Safety and Injury Prevention
e-Appointment Online
Health Buddy App